Global Life Science company

  • Heparin drug crystals

    Global Life Science company

  • Dog hair close up

    Committed to improving people, animal and plant health 

     

  • Strawberry extreme closeup

    Experts in animal-derived biomolecules

    https://www.bioiberica.com/en/products

We seek strategic collaborations with other companies or institutions in order to develop new businesses and products.

At Bioiberica we are committed to science, life and the future. That is why we are constantly evolving and wish to continue growing and innovating our human, animal and plant health solutions.

Let’s work together
  • Noticia
    Companion Animal Health

    Bioiberica launches Klorexivet®, an innovative spray formula that promotes the healing of pet wounds

    • Klorexivet® has dual protective and antiseptic action which cleanses, generates a suitable healing environment and prevents microbial overgrowth on the wound
    • The product is ideal for dogs and cats with superficial injuries as a result of dermatitis, skin infections or wounds, etc.
    • Klorexivet® expands the dermatology product range for pets
  • Noticia
    Plant Health

    Bioiberica to have an active participation in the 4thBiostimulants World Congress, held in Barcelona in November 2019

    • Our company will be present at the exhibitors’ area with their own booth, where they will showcase their eco-friendly solutions for plant stress and improvement of agronomical strategies in plant protection
    • The Biostimulants World Congress is the most important international event in biostimulants, and is to be attended by more than 750 companies from 60 countries

     

  • Noticia
    Bioiberica

    Reig Jofre acquires Bioiberica’s portfolio of finished pharmaceutical and nutraceutical products, and establishes a strategic agreement to develop the joint health market

    • The operation involves the acquisition of the portfolios of medical prescription and consumer healthcare products, the incorporation of specialized human resources and an agreement whereby Bioiberica will continue producing and supplying APIs and ingredients to Reig Jofre
    • Reig Jofre is diversifying the specialty products area with a new therapeutic area, Joint Health and Pain, a segment which is forecast to grow worldwide in the coming years, and is expanding its product portfolio with medicines for the treatment of osteoarthritis, including the incorporation of leading brands in the Spanish market, and its nutraceutical derivatives
    • The operation also includes the creation of a strategic agreement to develop the health care market in the joint pain area and to advance in the treatment of osteoarthritis